Literature DB >> 16481414

Acute myocardial infarction and kidney transplantation.

Bertram L Kasiske1, J Ross Maclean, Jon J Snyder.   

Abstract

Although the risk for acute myocardial infarction (AMI) is lower after transplantation than on the waiting list, this risk may vary by patient population and may be different early versus late after transplantation. Risk factors for AMI were examined among 53,297 Medicare beneficiaries who were placed on the deceased-donor waiting list in 1995 to 2002. Early (<or=3 mo) and late (>3 mo) effects of receiving a deceased- or living-donor kidney transplant were examined using time-dependent covariates in Cox nonproportional hazards analysis. Overall, transplantation was associated with a 17% lower adjusted risk for AMI (0.83; 95% confidence interval [CI] 0.77 to 0.90) versus the waiting list. However, the relative risk (versus the waiting list) for AMI was greater for deceased- compared to living-donor transplants, with both being much greater early (deceased-donor 3.57 [95% CI 3.21 to 3.96] compared to living-donor 2.81 [95% CI 2.31 to 3.42]) than late (deceased-donor 0.45 [95% CI 0.41 to 0.50] compared to living-donor 0.39 [95% CI 0.33 to 0.47]) posttransplantation. Individuals who were >or=65 yr of age had a much higher risk (versus 18- to 34-yr-olds) for AMI early posttransplantation (8.01; 95% CI 5.12 to 12.53) compared with the waiting list (3.68; 95% CI 3.98 to 4.54) or late posttransplantation (4.37; 95% CI 3.07 to 6.20). Black patients had less reduction in AMI risk (versus white patients) late posttransplantation (0.78; 95% CI 0.64 to 0.95) compared with early posttransplantation (0.60; 95% CI 0.48 to 0.74) or on the waiting list (0.62; 95% CI 0.56 to 0.68). The AMI risk that was associated with chronic kidney disease from diabetes (versus glomerulonephritis) was relatively greater on the waiting list (1.64; 95% CI 1.45 to 1.85) compared with early (1.34; 95% CI 1.08 to 1.68) and late (1.39; 95% CI 1.12 to 1.72) posttransplantation. Thus the risk reduction for AMI with transplantation versus the waiting list varies by patient population and time after transplantation.

Entities:  

Mesh:

Year:  2006        PMID: 16481414     DOI: 10.1681/ASN.2005090984

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  39 in total

1.  ST-Elevation Myocardial Infarction 33 Days after Lung Transplant in a Patient with Non-Significant CAD before Transplantation: A Case Report.

Authors:  Saeed Alipour Parsa; Isa Khaheshi; Amir Dousti; Farah Naghashzadeh; Bahar Ataeinia
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review.

Authors:  Krista L Lentine; Lisa A Rocca-Rey; Giuliana Bacchi; Nadia Wasi; Leslie Schmitz; Paolo R Salvalaggio; Kevin C Abbott; Mark A Schnitzler; Luca Neri; Daniel C Brennan
Journal:  Transplantation       Date:  2008-07-27       Impact factor: 4.939

3.  Does hybrid imaging have a role in cardiac risk evaluation of the pre-renal transplant patient?

Authors:  Abdul Hakeem; Sabha Bhatti; Su Min Chang
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

4.  Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients.

Authors:  Krista L Lentine; Mark A Schnitzler; Kevin C Abbott; Kosha Bramesfeld; Paula M Buchanan; Daniel C Brennan
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 8.237

5.  Use of ambulatory blood pressure monitoring in kidney transplant recipients.

Authors:  Adrian M Whelan; Elaine Ku
Journal:  Nephrol Dial Transplant       Date:  2019-09-01       Impact factor: 5.992

6.  Predictors and prognostic implications of major adverse cardiovascular events after renal transplant: 10 years outcomes in 321 patients.

Authors:  Waqas Aftab; Padmini Varadarajan; Shuja Rasool; Ramdas G Pai
Journal:  Int J Angiol       Date:  2014-06

7.  Pharmacokinetic interaction study of ticagrelor and cyclosporine in healthy volunteers.

Authors:  Renli Teng; Mirjana Kujacic; Judith Hsia
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

8.  Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure.

Authors:  Krista L Lentine; Lisa A Rocca Rey; Swathy Kolli; Giuliana Bacchi; Mark A Schnitzler; Kevin C Abbott; Huiling Xiao; Daniel C Brennan
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 8.237

Review 9.  Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies.

Authors:  Krista L Lentine; Frank P Hurst; Rahul M Jindal; Todd C Villines; Jeffrey S Kunz; Christina M Yuan; Paul J Hauptman; Kevin C Abbott
Journal:  Am J Kidney Dis       Date:  2009-09-23       Impact factor: 8.860

Review 10.  Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Suetonia C Palmer; Jonathan C Craig; Sankar D Navaneethan; Marcello Tonelli; Fabio Pellegrini; Giovanni F M Strippoli
Journal:  Ann Intern Med       Date:  2012-08-21       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.